BID is a critical factor controlling cell viability regulated by IFN-α

Journal of Immunotherapy

Volumn 35, Issue 1, 2012, Pages 23-31

  Tsuno, Takaya ^a   Mejido, Josef ^a   Zhao, Tongmao ^a   Phillips, Terry ^b   Myers, Timothy G ^c   Bekisz, Joseph ^a   Zoon, Kathryn C ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^c Microarray Research Facility   (United States)

Author keywords

apoptosis; BID; cell viability; IFN ; TRAIL

Indexed keywords

ALPHA2C INTERFERON; FAS LIGAND; INTERFERON RECEPTOR; PROTEIN BID; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CANCER CELL; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MITOCHONDRIAL MEMBRANE POTENTIAL; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION;

ADENOCARCINOMA; APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERON-ALPHA; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT; MEMBRANE POTENTIAL, MITOCHONDRIAL; OVARIAN NEOPLASMS; RECEPTOR, INTERFERON ALPHA-BETA; RNA, SMALL INTERFERING; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSGENES;

EID: 84155167173     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/CJI.0b013e3182372dcf     Document Type: Article

References (37)

1. Borden EC, Sen GC, Uze G, et al. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov. 2007;6:975-990.
2. Maher SG, Romero-Weaver AL, Scarzello AJ, et al. Inter-feron: cellular executioner or white knight? Curr Med Chem. 2007;14:1279-1289.
3. Parmar S, Platanias LC. Interferons: mechanisms of action and clinical applications. Curr Opin Oncol. 2003;15:431-439.
4. Jonasch E, Haluska FG. Interferon in oncological practice: review of interferon biology, clinical applications, and toxi-cities. Oncologist. 2001;6:34-55.
5. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science. 1998;281:1305-1308.
6. Petak I, Houghton JA. Shared pathways: death receptors and cytotoxic drugs in cancer therapy. Pathol Oncol Res. 2001; 7:95-106.
7. Fiorucci G, Vannucchi S, Chiantore MV, et al. TNF-related apoptosis-inducing ligand (TRAIL) as a pro-apoptotic signal transducer with cancer therapeutic potential. Curr Pharm Des. 2005;11:933-944.
8. Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 1995;3:673-682.
9. Tanaka H, Ito T, Kyo T, et al. Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients. Eur J Haematol. 2007;78:389-398.
10. Tsuno T, Mejido J, Zhao T, et al. IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha. J Immun-other. 2009;32:803-816.
11. Galluzzi L, Zamzami N, de La Motte Rouge T, et al. Methods for the assessment of mitochondrial membrane permeabiliza-tion in apoptosis. Apoptosis. 2007;12:803-813.
12. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science. 2004;305:626-629.
13. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med. 2000;6:513-519.
14. Chipuk JE, Fisher JC, Dillon CP, et al. Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins. Proc Natl Acad Sci USA. 2008;105:20327-20332.
15. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev. 2007;87:99-163.
16. Gonzalvez F, Pariselli F, Dupaigne P, et al. tBid interaction with cardiolipin primarily orchestrates mitochondrial dysfunctions and subsequently activates Bax and Bak. Cell Death Differ. 2005;12:614-626.
17. Kroemer G, Martin SJ. Caspase-independent cell death. Nat Med. 2005;11:725-730.
18. Scaffidi C, Fulda S, Srinivasan A, et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998;17:1675-1687.
19. Zamzami N, El Hamel C, Maisse C, et al. Bid acts on the permeability transition pore complex to induce apoptosis. Oncogene. 2000;19:6342-6350.
20. Zha J, Weiler S, Oh KJ, et al. Posttranslational N-myristoyla-tion of BID as a molecular switch for targeting mitochondria and apoptosis. Science. 2000;290:1761-1765.
21. Chipuk JE, Green DR. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol. 2008;18:157-164.
22. Rostovtseva TK, Antonsson B, Suzuki M, et al. but not Bax, regulates VDAC channels. J Biol Chem. 2004;279: 13575-13583.
23. Cowling V, Downward J. Caspase-6 is the direct activator of caspase-8 in the cytochrome c-induced apoptosis pathway: absolute requirement for removal of caspase-6 prodomain. Cell Death Differ. 2002;9:1046-1056.
24. Sun XM, MacFarlane M, Zhuang J, et al. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem. 1999;274:5053-5060.
25. Li H, Zhu H, Xu CJ, et al. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 1998;94:491-501.
26. Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997;91:479-489.
27. Czapski GA, Cakala M, Kopczuk D, et al. Effect of poly(ADP-ribose) polymerase inhibitors on oxidative stress evoked hydroxyl radical level and macromolecules oxidation in cell free system of rat brain cortex. Neurosci Lett. 2004; 356:45-48.
28. Parsons JL, Dianova II, Allinson SL, et al. Poly(ADP-ribose) polymerase-1 protects excessive DNA strand breaks from deterioration during repair in human cell extracts. FEBS J. 2005;272:2012-2021.
29. Smulson ME, Pang D, Jung M, et al. Irreversible binding of poly(ADP)ribose polymerase cleavage product to DNA ends revealed by atomic force microscopy: possible role in apoptosis. Cancer Res. 1998;58:3495-3498.
30. Hu R, Bekisz J, Hayes M, et al. Divergence of binding, signaling, and biological responses to recombinant human hybrid IFN. J Immunol. 1999;163:854-860.
31. Han J, Lee H, Nguyen NY, et al. Novel multiple 5-amino-modified primer for DNA microarrays. Genomics. 2005; 86:252-258.
32. Phillips TM. Analysis of single-cell cultures by immunoaffinity capillary electrophoresis with laser-induced fluorescence detection. Luminescence. 2001;16:145-152.
33. Phillips TM, Dickens BF. Analysis of recombinant cytokines in human body fluids by immunoaffinity capillary electrophor-esis. Electrophoresis. 1998;19:2991-2996.
34. Smiley ST, Reers M, Mottola-Hartshorn C, et al. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci USA. 1991;88:3671-3675.
35. Shelton SN, Shawgo ME, Robertson JD. Cleavage of Bid by executioner caspases mediates feed forward amplification of mitochondrial outer membrane permeabilization during geno-toxic stress-induced apoptosis in Jurkat cells. J Biol Chem. 2009;284:11247-11255.
36. Banerjee J, Ghosh S. Bax increases the pore size of rat brain mitochondrial voltage-dependent anion channel in the presence of tBid. Biochem Biophys Res Commun. 2004;323: 310-314.
37. Shimizu S, Narita M, Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature. 1999;399:483-487.